Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes.
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes. Metabolism. 2018 08; 85:32-37.
View in:
PubMed
subject areas
Adiponectin
Aged
Biomarkers
Blood Glucose
Canagliflozin
C-Reactive Protein
Diabetes Mellitus, Type 2
Double-Blind Method
Humans
Hypoglycemic Agents
Inflammation
Leptin
Male
Metformin
Middle Aged
Molybdoferredoxin
Sulfonylurea Compounds
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
W. Timothy Garvey